A 54-year-old man was diagnosed with descending colon cancer with metastases in the liver, para-aortic lymph nodes, and penis, and chemotherapy was introduced after construction of a colostomy. The patient reported only mild penile pain at the time of diagnosis; however, the pain gradually worsened and interfered with his daily life. Opioids did not provide sufficient analgesia, and the patient developed dysuria and priapism. Through construction of a cystostomy, palliative radiotherapy with QUAD Shot regimen (14 Gy in 4 fractions twice-daily on 2 days repeated every 4 weeks) to the penile metastasis was started for pain relief and tumor shrinkage. The radiation rapidly improved the penile symptoms, enabling opioid reduction and cystostomy removal. The patient remained pain-free and able to urinate on his own until his death. Metastatic penile tumors are rare, especially those derived from colon cancer. Penile metastases occur mainly in the late stages of cancer and may impair the patient's quality of life. In such cases, palliative radiotherapy, especially with QUAD Shot regimen, is useful with short treatment time, durable symptom control, and little adverse effect, maintaining quality of life.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212838 | PMC |
http://dx.doi.org/10.1007/s13691-023-00604-y | DOI Listing |
Case Rep Oncol Med
October 2024
Radiation Oncology Unit College of Medicine King Saud University, Riyadh, Saudi Arabia.
Interferenceless-coded aperture correlation holography (I-COACH) is a promising single-shot 3D imaging method in which a coded phase mask (CPM) is used to encode 3D information about an object into an intensity distribution. However, conventional CPM encoding methods usually lead to intensity dilution, especially in the recording of point spread holograms (PSHs), resulting in low-resolution reconstruction of I-COACH. Here, we propose accelerating quad Airy beams with four mainlobes as a point response to enable weak diffraction propagation and a sharp maximum intensity in the transverse direction.
View Article and Find Full Text PDFHead Neck
June 2024
Department of Radiation Oncology, Tata Medical Center, Kolkata, West Bengal, India.
Background: This study assessed a palliative radiotherapy regimen using daily radiation over 4 days for three courses in inoperable head and neck cancers, emphasizing oral primary cancers.
Methods: Retrospective data of 116 patients treated with a daily dose of 3.6-3.
Oral Oncol
April 2024
Department of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan. Electronic address:
Cancers (Basel)
March 2024
Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Objectives: Patients with recurrent and metastatic head and neck cancer (HNC) have limited treatment options. 'QuadShot' (QS), a hypofractionated palliative radiotherapy regimen, can provide symptomatic relief and local control and may potentiate the effects of immune checkpoint inhibitors (ICIs). We compared outcomes of QS ± concurrent ICIs in the palliative treatment of HNC.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!